Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CDP323

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Phenylalanine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
α4β7 integrin inhibitors: a patent review
ABSTRACT Introduction: The α4β7 integrin is heterodimeric cell surface receptors expressed on most leukocytes. Mucosal addressing… Expand
2014
2014
In Vitro Hydrolysis and Transesterification of CDP323, an α4β1/α4β7 Integrin Antagonist Ester Prodrug
We identified the enzyme(s) involved in the hydrolysis of the ethyl ester prodrug CDP323 (C28H29BrN403) and characterized its… Expand
  • table 1
  • table 2
  • table 3
2013
2013
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study
Background Lymphocyte inhibition by antagonism of α4 integrins is a validated therapeutic approach for relapsing multiple… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 3
2013
2013
In Vitro Hydrolysis and Transesterification of CDP 323 , an a 4 b 1 / a 4 b 7 Integrin Antagonist Ester Prodrug
We identified the enzyme(s) involved in the hydrolysis of the ethyl ester prodrug CDP323 (C28H29BrN403) and characterized its… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE